Malignant neoplasm of labium minus
- C51.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C51.1 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C51.1 – other international versions of ICD-10 C51.1 may differ.
ICD-10-CM Coding Rules
- C51.1 is applicable to female patients.
The following code(s) above C51.1 contain annotation back-references
that may be applicable to C51.1:
- C00-D49 Neoplasms
- C51-C58 Malignant neoplasms of female genital organs
- C51 Malignant neoplasm of vulva
Approximate Synonyms
- Cancer of the labia minora
- Primary malignant neoplasm of labia minora
ICD-10-CM C51.1 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
- 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
- 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
- 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
- 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
- 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
- 754 Malignancy, female reproductive system with mcc
- 755 Malignancy, female reproductive system with cc
- 756 Malignancy, female reproductive system without cc/mcc
Convert C51.1 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Diagnosis Index entries containing back-references to C51.1: